NCT03691792

Brief Summary

Major depression is a highly prevalent, chronic, and debilitating mental health problem with significant social cost that poses a tremendous economic burden. Winter seasonal affective disorder (SAD) is a subtype of recurrent major depression that affects 5% of the population (14.5 million Americans), involving substantial depressive symptoms for about 5 months of each year during most years, beginning in young adulthood.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2018

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2018

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

June 3, 2025

Status Verified

June 1, 2024

Enrollment Period

6.5 years

First QC Date

September 28, 2018

Last Update Submit

May 28, 2025

Conditions

Keywords

cognitive-behavioral therapylight therapybiomarkerstreatment mechanisms

Outcome Measures

Primary Outcomes (2)

  • Structured Interview Guide for the Hamilton Rating Scale for Depression-Seasonal Affective Disorder Version (SIGH-SAD)

    Semi-structured interview of depressive symptoms

    past 1 week

  • Beck Depression Inventory-Second Edition (BDI-II)

    self-report measure of depressive symptoms

    past 2 weeks

Study Arms (2)

Cognitive-Behavioral Therapy (CBT-SAD)

EXPERIMENTAL

12 1.5-hour group sessions at a rate of 2 sessions per week over 8 weeks.

Behavioral: Cognitive-Behavioral Therapy (CBT-SAD)

Light Therapy

ACTIVE COMPARATOR

6 weeks of daily light therapy at home, using a 10,000-lux light box beginning at 30 minutes upon waking, with dose subsequently adjusted per treatment algorithm.

Other: Light Therapy

Interventions

12 group sessions over 6 weeks

Also known as: CBT-SAD
Cognitive-Behavioral Therapy (CBT-SAD)

10,000-lux initiated at 30 min upon waking and adjusted per treatment algorithm, continuing for 6 weeks

Light Therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Principle DSM-5 diagnosis of Major Depression, Recurrent, with Seasonal Pattern. -Meet Structured Interview Guide for the Hamilton Rating Scale for Depression-Seasonal Affective Disorder Version (SIGH-SAD) criteria for a current SAD episode (see below).
  • No use or stable use of antidepressants (i.e., a consistent dose of the same medication maintained for \> 4 weeks with no plans to change).

You may not qualify if:

  • Current or past light therapy or CBT for SAD.
  • Presence of a comorbid Axis I disorder that requires immediate treatment (i.e., bipolar disorder, psychotic disorders, substance use disorder).
  • Acute and serious suicidal intent.
  • Planned absences of \>1 week from the area through March.
  • History of conditions that are known contra-indications to LT, including conditions associated with toxicity of bright light to the retina (i.e., macular degeneration or any retinopathy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vermont, Psychology Department

Burlington, Vermont, 05405-0134, United States

Location

Related Publications (1)

  • Rohan KJ, Franzen PL, Roeckelin KA, Siegle GJ, Kolko DJ, Postolache TT, Vacek PM. Elucidating treatment targets and mediators within a confirmatory efficacy trial: study protocol for a randomized controlled trial of cognitive-behavioral therapy vs. light therapy for winter depression. Trials. 2022 May 12;23(1):383. doi: 10.1186/s13063-022-06330-9.

MeSH Terms

Conditions

Seasonal Affective Disorder

Interventions

Cognitive Behavioral TherapyPhototherapy

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesTherapeutics

Study Officials

  • Kelly J Rohan, Ph.D.

    University of Vermont

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes are rated on a semi-structured interview by raters blind to treatment assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: head-to-head RCT
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 28, 2018

First Posted

October 2, 2018

Study Start

September 1, 2018

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

June 3, 2025

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

Study data will be provided to the NIMH Data Archive

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
After publication of the study results.
More information

Locations